Trichomonas Vaginalis
6
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
9 treatments under study, led by Selfreported Risk Screening For Prep And Syndromic Management For Stis
Research Leaders
14 sponsors active, led by National Institute of Allergy and Infectious Diseases (NIAID)
Related Conditions
Often studied with 15 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) Study
Clinical Study of STI Screening to Prevent Adverse Birth and New-born Outcomes (Philani Ndiphile)
"Solana™ Trichomonas Assay Field Study"
Female Urine, Vaginal & Endocervical Swab & Cervical Specimen Collections for APTIMA Trichomonas Vaginalis Assay Testing
Accuracy and Acceptability of Self-Diagnostic Methods for Vaginitis in Adolescent Females
Study to Improve Partner Services for STD Prevention
Research Network
Common Treatments
- Selfreported Risk Screening For Prep And Syndromic Management For Stis1
- Aptima Trichomonas Vaginalis Atv Assay1
- Patientdelivered Partner Treatment1
- Solana Trichomonas Assay Testing1
- Point Of Care Tests1
Active Sponsors
- National Institute of Allergy and Infectious Diseases (NIAID)3
- Quidel Corporation1
- Bill and Melinda Gates Foundation1
- Louisiana State University Health Sciences Center in New Orleans1
- Abbott1
Top Investigators
Johns Hopkins School of Medicine
Foundation for Professional Development
Tulane University School of Public Health and Tropical Medicine
Children's Hospital Medical Center, Cincinnati
USC Keck School of Medicine - University of Southern California
Related Conditions
- Gonorrhea Female1
- Hivaids1
- Antenatal Care1
- Birth Outcomes1
- Chlamydia Trachomatis1